Helvea

Baader Helvea is a specialized European investment bank and brokerage firm that serves as a critical research and advisory partner within the life sciences and healthcare sectors. Originally founded as Helvea SA in Geneva, the firm was acquired by Baader Bank in 2013 and has since integrated its operations to provide deep-dive equity research, corporate finance, and brokerage services focused on Swiss and European markets. The company is particularly well-regarded for its healthcare and biotechnology coverage, hosting major industry conferences and providing valuation analysis for mid-cap and large-cap pharmaceutical entities. While not a drug developer itself, Baader Helvea acts as a key intermediary for capital markets activity and strategic investment in the healthcare industry.